Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC |
Duato JoaquinVice Chair, Exec Committee
|
GrantPerformance Share Units · Derivative | 27,738 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002088 · doc4.xml · derivative · entry 2 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,738 Underlying: Common Stock · 27,738 shares Expires not disclosed F2 · derivative.exercise_price: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. F2 · derivative.expiration_date: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC |
Duato JoaquinVice Chair, Exec Committee
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 114,776 | $0.00 Strike: $164.62 | $0.00 |
DisclosureSEC source: 0001225208-21-002088 · doc4.xml · derivative · entry 1 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,776 Underlying: Common Stock · 114,776 shares Expires 2031-02-08 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC |
Decker Robert JController, CAO
|
GrantRestricted Share Units · Derivative | 655 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002089 · doc4.xml · derivative · entry 3 Decker Robert J · CIK 0001798703 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655 Underlying: Common Stock · 655 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC |
Decker Robert JController, CAO
|
GrantPerformance Share Units · Derivative | 655 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002089 · doc4.xml · derivative · entry 2 Decker Robert J · CIK 0001798703 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655 Underlying: Common Stock · 655 shares Expires not disclosed F2 · derivative.exercise_price: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. F2 · derivative.expiration_date: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC |
Decker Robert JController, CAO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 7,191 | $0.00 Strike: $164.62 | $0.00 |
DisclosureSEC source: 0001225208-21-002089 · doc4.xml · derivative · entry 1 Decker Robert J · CIK 0001798703 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,191 Underlying: Common Stock · 7,191 shares Expires 2031-02-08 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
GrantRestricted Share Units · Derivative | 2,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002090 · doc4.xml · derivative · entry 3 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,135 Underlying: Common Stock · 2,135 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
GrantPerformance Share Units · Derivative | 10,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002090 · doc4.xml · derivative · entry 2 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,813 Underlying: Common Stock · 10,813 shares Expires not disclosed F2 · derivative.exercise_price: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. F2 · derivative.expiration_date: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 46,888 | $0.00 Strike: $164.62 | $0.00 |
DisclosureSEC source: 0001225208-21-002090 · doc4.xml · derivative · entry 1 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,888 Underlying: Common Stock · 46,888 shares Expires 2031-02-08 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC |
Wolk Joseph JExec VP, CFO
|
GrantRestricted Share Units · Derivative | 3,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002091 · doc4.xml · derivative · entry 3 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,686 Underlying: Common Stock · 3,686 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC |
Wolk Joseph JExec VP, CFO
|
GrantPerformance Share Units · Derivative | 2,543 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002091 · doc4.xml · derivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,543 Underlying: Common Stock · 2,543 shares Expires not disclosed F2 · derivative.exercise_price: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. F2 · derivative.expiration_date: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC |
Wolk Joseph JExec VP, CFO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 80,976 | $0.00 Strike: $164.62 | $0.00 |
DisclosureSEC source: 0001225208-21-002091 · doc4.xml · derivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,976 Underlying: Common Stock · 80,976 shares Expires 2031-02-08 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC |
Ullmann Michael HExec VP, General Counsel
|
GrantRestricted Share Units · Derivative | 2,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002092 · doc4.xml · derivative · entry 3 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,580 Underlying: Common Stock · 2,580 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC |
Ullmann Michael HExec VP, General Counsel
|
GrantPerformance Share Units · Derivative | 12,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002092 · doc4.xml · derivative · entry 2 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,133 Underlying: Common Stock · 12,133 shares Expires not disclosed F2 · derivative.exercise_price: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. F2 · derivative.expiration_date: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC |
Ullmann Michael HExec VP, General Counsel
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 56,669 | $0.00 Strike: $164.62 | $0.00 |
DisclosureSEC source: 0001225208-21-002092 · doc4.xml · derivative · entry 1 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,669 Underlying: Common Stock · 56,669 shares Expires 2031-02-08 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC |
Stoffels PaulusVice Chair, Exec Committee
|
GrantRestricted Share Units · Derivative | 5,605 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002093 · doc4.xml · derivative · entry 3 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,605 Underlying: Common Stock · 5,605 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC |
Stoffels PaulusVice Chair, Exec Committee
|
GrantPerformance Share Units · Derivative | 29,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002093 · doc4.xml · derivative · entry 2 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,452 Underlying: Common Stock · 29,452 shares Expires not disclosed F2 · derivative.exercise_price: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. F2 · derivative.expiration_date: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC |
Stoffels PaulusVice Chair, Exec Committee
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 123,118 | $0.00 Strike: $164.62 | $0.00 |
DisclosureSEC source: 0001225208-21-002093 · doc4.xml · derivative · entry 1 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,118 Underlying: Common Stock · 123,118 shares Expires 2031-02-08 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:47 UTC |
Mongon ThibautExec VP, WW Chair, Consumer
|
GrantRestricted Share Units · Derivative | 3,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002094 · doc4.xml · derivative · entry 3 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,163 Underlying: Common Stock · 3,163 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:47 UTC |
Mongon ThibautExec VP, WW Chair, Consumer
|
GrantPerformance Share Units · Derivative | 3,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002094 · doc4.xml · derivative · entry 2 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,573 Underlying: Common Stock · 3,573 shares Expires not disclosed F2 · derivative.exercise_price: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. F2 · derivative.expiration_date: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:47 UTC |
Mongon ThibautExec VP, WW Chair, Consumer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 69,470 | $0.00 Strike: $164.62 | $0.00 |
DisclosureSEC source: 0001225208-21-002094 · doc4.xml · derivative · entry 1 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,470 Underlying: Common Stock · 69,470 shares Expires 2031-02-08 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:47 UTC |
Sneed Michael EEVP, Global Corp Aff & CCO
|
GrantRestricted Share Units · Derivative | 1,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002095 · doc4.xml · derivative · entry 3 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,493 Underlying: Common Stock · 1,493 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:47 UTC |
Sneed Michael EEVP, Global Corp Aff & CCO
|
GrantPerformance Share Units · Derivative | 7,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002095 · doc4.xml · derivative · entry 2 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,737 Underlying: Common Stock · 7,737 shares Expires not disclosed F2 · derivative.exercise_price: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. F2 · derivative.expiration_date: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:47 UTC |
Sneed Michael EEVP, Global Corp Aff & CCO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 32,793 | $0.00 Strike: $164.62 | $0.00 |
DisclosureSEC source: 0001225208-21-002095 · doc4.xml · derivative · entry 1 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,793 Underlying: Common Stock · 32,793 shares Expires 2031-02-08 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:47 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
GrantRestricted Share Units · Derivative | 3,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002096 · doc4.xml · derivative · entry 3 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,739 Underlying: Common Stock · 3,739 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:47 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
GrantPerformance Share Units · Derivative | 11,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002096 · doc4.xml · derivative · entry 2 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,429 Underlying: Common Stock · 11,429 shares Expires not disclosed F2 · derivative.exercise_price: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. F2 · derivative.expiration_date: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:47 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 82,127 | $0.00 Strike: $164.62 | $0.00 |
DisclosureSEC source: 0001225208-21-002096 · doc4.xml · derivative · entry 1 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,127 Underlying: Common Stock · 82,127 shares Expires 2031-02-08 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:47 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
GrantRestricted Share Units · Derivative | 3,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002097 · doc4.xml · derivative · entry 3 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,136 Underlying: Common Stock · 3,136 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:47 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
GrantPerformance Share Units · Derivative | 11,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002097 · doc4.xml · derivative · entry 2 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,034 Underlying: Common Stock · 11,034 shares Expires not disclosed F2 · derivative.exercise_price: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. F2 · derivative.expiration_date: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:47 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 68,894 | $0.00 Strike: $164.62 | $0.00 |
DisclosureSEC source: 0001225208-21-002097 · doc4.xml · derivative · entry 1 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,894 Underlying: Common Stock · 68,894 shares Expires 2031-02-08 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:47 UTC |
Gorsky AlexDirector · Chairman, CEO
|
GrantRestricted Share Units · Derivative | 11,066 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002098 · doc4.xml · derivative · entry 8 Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,066 Underlying: Common Stock · 11,066 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:47 UTC |
Gorsky AlexDirector · Chairman, CEO
|
GrantPerformance Share Units · Derivative | 63,088 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002098 · doc4.xml · derivative · entry 7 Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,088 Underlying: Common Stock · 63,088 shares Expires not disclosed F2 · derivative.exercise_price: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. F2 · derivative.expiration_date: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:47 UTC |
Gorsky AlexDirector · Chairman, CEO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 243,072 | $0.00 Strike: $164.62 | $0.00 |
DisclosureSEC source: 0001225208-21-002098 · doc4.xml · derivative · entry 6 Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,072 Underlying: Common Stock · 243,072 shares Expires 2031-02-08 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 00:04 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
GrantRestricted Share Units · Derivative | 1,971 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002106 · doc4.xml · derivative · entry 3 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,971 Underlying: Common Stock · 1,971 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 00:04 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
GrantPerformance Share Units · Derivative | 8,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002106 · doc4.xml · derivative · entry 2 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,704 Underlying: Common Stock · 8,704 shares Expires not disclosed F2 · derivative.exercise_price: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. F2 · derivative.expiration_date: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 00:04 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 43,293 | $0.00 Strike: $164.62 | $0.00 |
DisclosureSEC source: 0001225208-21-002106 · doc4.xml · derivative · entry 1 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,293 Underlying: Common Stock · 43,293 shares Expires 2031-02-08 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| December 09, 2020 Filed Dec 10, 2020 23:19 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 54,662 | $0.00 Strike: $62.20 | $0.00 |
DisclosureSEC source: 0001225208-20-014529 · doc4.xml · derivative · entry 5 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,662 shares Expires 2021-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2020 Filed Dec 10, 2020 23:19 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
SaleCommon Stock | 54,662 | $152.93 | $8,359,459.66 |
DisclosureSEC source: 0001225208-20-014529 · doc4.xml · nonDerivative · entry 2 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,079 F1 · price: This transaction was executed in multiple trades at prices ranging from $152.55 to $153.385. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 09, 2020 Filed Dec 10, 2020 23:19 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
Exercise / conversionCommon Stock | 54,662 | $62.20 | $3,399,976.40 |
DisclosureSEC source: 0001225208-20-014529 · doc4.xml · nonDerivative · entry 1 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 23:19 UTC |
HEWSON MARILLYN ADirector
|
GrantDeferred Share Units · Derivative | 213.751 | $149.21 | $31,893.79 |
DisclosureSEC source: 0001225208-20-014530 · doc4.xml · derivative · entry 1 HEWSON MARILLYN A · CIK 0001217496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,088.75 Underlying: Common Stock · 213.751 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 23:20 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 354.873 | $149.21 | $52,950.60 |
DisclosureSEC source: 0001225208-20-014531 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,078.1733 Underlying: Common Stock · 354.873 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 23:20 UTC |
WEINBERGER MARK ADirector
|
GrantDeferred Share Units · Derivative | 213.751 | $149.21 | $31,893.79 |
DisclosureSEC source: 0001225208-20-014532 · doc4.xml · derivative · entry 1 WEINBERGER MARK A · CIK 0001785997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,088.75 Underlying: Common Stock · 213.751 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| November 25, 2020 Filed Feb 10, 2021 23:47 UTC |
Gorsky AlexDirector · Chairman, CEO
|
GiftCommon Stock | 13,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002098 · doc4.xml · nonDerivative · entry 3 Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,819.527 Read SEC document |
| November 25, 2020 Filed Feb 10, 2021 23:47 UTC |
Gorsky AlexDirector · Chairman, CEO
|
GiftCommon Stock | 6,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002098 · doc4.xml · nonDerivative · entry 2 Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 446,779.527 Read SEC document |
| September 14, 2020 Filed Feb 10, 2021 23:47 UTC |
Gorsky AlexDirector · Chairman, CEO
|
OtherCommon Stock | 2,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002098 · doc4.xml · nonDerivative · entry 1 Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 453,751 Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 20:58 UTC |
HEWSON MARILLYN ADirector
|
GrantDeferred Share Units · Derivative | 212.569 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-011409 · doc4.xml · derivative · entry 1 HEWSON MARILLYN A · CIK 0001217496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,874.999 Underlying: Common Stock · 212.569 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 20:58 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 352.909 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-011410 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,723.3003 Underlying: Common Stock · 352.909 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 20:58 UTC |
WEINBERGER MARK ADirector
|
GrantDeferred Share Units · Derivative | 212.569 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-011411 · doc4.xml · derivative · entry 1 WEINBERGER MARK A · CIK 0001785997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,874.999 Underlying: Common Stock · 212.569 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 18:58 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 7,877 | $0.00 Strike: $65.37 | $0.00 |
DisclosureSEC source: 0001225208-20-011289 · doc4.xml · derivative · entry 8 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,877 shares Expires 2022-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 18:58 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 8,238 | $0.00 Strike: $62.20 | $0.00 |
DisclosureSEC source: 0001225208-20-011289 · doc4.xml · derivative · entry 7 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,238 shares Expires 2021-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 18:58 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
SaleCommon Stock | 8,238 | $153.53 | $1,264,755.43 |
DisclosureSEC source: 0001225208-20-011289 · doc4.xml · nonDerivative · entry 4 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,419.5041 F2 · price: This transaction was executed in multiple trades at prices ranging from $153.51 to $153.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.